7th Sep 2007 17:30
Elsevier, the leading publisher of scientific, technical andmedical information products and services, today announced the launchof OncologySTAT (http://www.oncologystat.com), a free websitefeaturing high-quality, scientifically-based oncology and cancer careinformation and education. The site is aimed at more than 1 million USoncologists, hematologists, oncology nurses, and all other healthcareprofessionals involved in the treatment, care and diagnosis ofpatients with cancer. OncologySTAT is advertiser supported and thefirst online community of its kind launched by a scholarly publisher. £ OncologySTAT offers multiple professional cancer informationresources in a single online location. Healthcare professionals whoregister with the site can search and download current peer-reviewedarticles from more than 100 Elsevier cancer related journals.Clinicians can stay up to date and build expertise leading to improvedpatient care and enhanced practice management through features such asjournal and MEDLINE search, professional drug and interactiondatabases, news, blogs and webinars. OncologySTAT also provides cancerpatients, survivors and caregivers with access to the same informationused by experienced cancer care professionals. £ "OncologySTAT offers resources to improve cancer diagnosis,treatment, and prevention in one source at no cost to clinicians,"says Lee S. Schwartzberg, M.D., F.A.C.P., physician and head ofresearch, The West Clinic, OncologySTAT Advisory Board Co-Chairman andEditor-in-Chief. "No other online destination offers such a breadth ofintegrated scientifically-based cancer research, information andeducation for free." £ Meeting an Identified Need £ Oncology is the second largest and fastest growing therapy classin the world. Cancer professionals are challenged by the multitude ofinformation sources available, and by the frequency in which newinformation is published. £ "Oncologists who are classified as heavy online users may visitcancer-related websites four to five times per day to access thelatest scientific information," says Axel Grothey M.D., OncologySTATAdvisory Board Member and Associate Editor. "Oncologists research theweb more often than any clinical specialty because there are more than500 cancer drugs in the pipeline. Clinicians want to know when thesedrugs will become available and how patients may tolerate various drugcombinations." £ OncologySTAT's professional information features include thefollowing: £ -- Peer-reviewed Journal Articles: registered users can search and access current journal articles from over 100 Elsevier cancer related journals including The Lancet Oncology, The Breast, Lung Cancer, Cancer Letters, The American Journal of Medicine, Seminars in Oncology, Seminars in Radiation Oncology, Seminars in Hematology, Blood Reviews, etc. £ -- Journal Scans: Weekly professional summaries of the most important scientific research from 25 leading cancer journals, including Journal of Clinical Oncology, Journal of the National Cancer Institute, CA: A Cancer Journal for Clinicians, Blood, JAMA, and New England Journal of Medicine. £ -- Cancer News Feeds: Late-breaking regulatory and drug approval updates from the widely respected Pink Sheet, as well as professional medical and conference news from the International Medical News Group and MDConsult. £ -- InfoBlast E-Newsletter: A weekly e-newsletter highlighting key oncology news, research and site content features. £ -- Integrated MEDLINE Search: Immediate access to search MEDLINE's vast repository of scientific abstracts without exiting OncologySTAT. £ -- Cancer-type "Spotlights": 27 cancer type "Spotlight" sections featuring news, journals, article scans, clinical texts summaries, patient handouts and webinars on cancers such as bone, breast, prostate and lung. £ -- Chemotherapy Regimens: Guidelines and protocols from the Elsevier Guide to Oncology Drugs and Regimens (2006) obtained through searches by drug or cancer type. £ -- Professional Drug Monograph and Interactions Database: Powered by Gold Standard. £ "OncologySTAT is a first for getting a broad range of the latestevidence-based oncology information and news into the hands of healthprofessionals in a manner that fits the practitioner's workflow andtime-constraints, so they can spend more time treating patients," saidBrian Nairn, CEO, Elsevier Health Sciences. "OncologySTAT matches theuser's need for rapid integrated access to the latest trusted oncologyinformation with the pharmaceutical industry's growing need and desireto communicate directly with oncology practitioners via credibleonline channels." £ The site operates independently from any particular professionalsociety or sponsor. However, the site offers multiple marketing andpromotional opportunities, including targeted advertising andsponsorship of specific site sections or content types. £ The OncologySTAT advisory board includes 10 of the mostinfluential names in oncology, including four past-presidents of theAmerican Society of Clinical Oncology (ASCO). The editorial teamincludes Lee Schwartzberg M.D., F.A.C.P, OncologySTAT Editor in Chief,Axel Grothey, M.D., Associate Editor, and a team of seasonedprofessional medical writers and oncology fellows. £ About Elsevier £ Elsevier is a world-leading publisher of scientific, technical andmedical information products and services. Working in partnership withthe global science and health communities, Elsevier's 7,000 employeesin over 70 offices worldwide publish more than 2,000 journals and1,900 new books per year, in addition to offering a suite ofinnovative electronic products, such as Science Direct.(http://www.sciencedirect.com/), MDConsult(http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),bibliographic databases, and online reference works. £ Elsevier (http://www.elsevier.com/) is a global businessheadquartered in Amsterdam, The Netherlands and has offices worldwide.Elsevier is part of Reed Elsevier Group plc(http://www.reedelsevier.com/), a world-leading publisher andinformation provider. Operating in the science and medical, legal,education and business-to-business sectors, Reed Elsevier provideshigh-quality and flexible information solutions to users, withincreasing emphasis on the Internet as a means of delivery. ReedElsevier's ticker symbols are REN (Euronext Amsterdam), REL (LondonStock Exchange), RUK and ENL (New York Stock Exchange). Copyright Business Wire 2007Related Shares:
Relx